Industry

Unlike many other countries, Norway uses relatively few animals for industrial purposes, as the statistics for animal use show.

However, the development and testing of fish vaccines for the fish farming industry use large numbers of animals, which account for over 90% of all research animals on a yearly basis. Norecopa is in dialogue with all the vaccine companies in Norway to discuss ways of reducing the numbers of animals used. This was also the subject of an international Symposium on Challenges of Quality Requirements for Fish Vaccines which was arranged in Oslo in May 2016 by the European Directorate for the Quality of Medicines and Healthcare, EDQM.

Relatively few industrial companies have research facilities in Norway. Those that do can be seen on this list of animal facilities in Norway.

The EU's REACH regulation (Registration, Evaluation, Authorisation and Restriction of Chemicals) is currently causing widespread concern because of the large number of research animals needed to implement it. The Replacement/Reduction potential in REACH was the subject of a presentation at a Danish event on 29 April 2016 to mark Forsøgsdyrenes Dag.

Did you find what you were looking for?

Yes, I found it! No, I did not!

Thanks for your feedback! Please note that we cannot respond unless you supply your email address.

What are you looking for?

Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.

Please contact us by email if you have any questions.

Thanks for your feedback! Please note that we cannot respond unless you supply your email address.



 

Abonnér på nyhetsbrevene fra Norecopa